Literature DB >> 19843455

Factor XA binding to phosphatidylserine-containing membranes produces an inactive membrane-bound dimer.

Tilen Koklic1, Rinku Majumder, Gabriel E Weinreb, Barry R Lentz.   

Abstract

Factor Xa (FXa) has a prominent role in amplifying both inflammation and the coagulation cascade. In the coagulation cascade, its main role is catalyzing the proteolytic activation of prothrombin to thrombin. Efficient proteolysis is well known to require phosphatidylserine (PS)-containing membranes that are provided by platelets in vivo. However, soluble, short-chain PS also triggers efficient proteolytic activity and formation of an inactive FXa dimer in solution. In this work, we ask whether PS-containing membranes also trigger formation of an inactive FXa dimer. We determined the proteolytic activity of human FXa toward human Pre2 as a substrate both at fixed membrane concentration (increasing FXa concentration) and at fixed FXa concentration (increasing membrane concentration). Neither of these experiments showed the expected behavior of an increase in activity as FXa bound to membranes, but instead suggested the existence of a membrane-bound inactive form of FXa. We found also that the fluorescence of fluorescein attached to FXa's active site serine was depolarized in a FXa concentration-dependent fashion in the presence of membranes. The fluorescence lifetime of FXa labeled in its active sites with a dansyl fluorophore showed a similar concentration dependence. We explained all these observations in terms of a quantitative model that takes into account dimerization of FXa after binding to a membrane, which yielded estimates of the FXa dimerization constant on a membrane as well as the kinetic constants of the dimer, showing that the dimer is effectively inactive.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19843455      PMCID: PMC2764068          DOI: 10.1016/j.bpj.2009.07.043

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  35 in total

1.  Changes in spatial arrangement between individual Ca-ATPase polypeptide chains in response to phospholamban phosphorylation.

Authors:  L Chen; Q Yao; K Brungardt; T Squier; D Bigelow
Journal:  Ann N Y Acad Sci       Date:  1998-09-16       Impact factor: 5.691

Review 2.  Procoagulant expression in platelets and defects leading to clinical disorders.

Authors:  N O Solum
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-12       Impact factor: 8.311

3.  Association of factor V activity with membranous vesicles released from human platelets: requirement for platelet stimulation.

Authors:  A P Bode; H Sandberg; F A Dombrose; B R Lentz
Journal:  Thromb Res       Date:  1985-07-01       Impact factor: 3.944

Review 4.  Blood coagulation.

Authors:  C M Jackson; Y Nemerson
Journal:  Annu Rev Biochem       Date:  1980       Impact factor: 23.643

5.  The contribution of bovine Factor V and Factor Va to the activity of prothrombinase.

Authors:  M E Nesheim; J B Taswell; K G Mann
Journal:  J Biol Chem       Date:  1979-11-10       Impact factor: 5.157

6.  Role of procoagulant lipids in human prothrombin activation. 2. Soluble phosphatidylserine upregulates and directs factor X(a) to appropriate peptide bonds in prothrombin.

Authors:  Mou Banerjee; Rinku Majumder; Gabriel Weinreb; Jianfang Wang; Barry R Lentz
Journal:  Biochemistry       Date:  2002-01-22       Impact factor: 3.162

7.  Role of procoagulant lipids in human prothrombin activation. 1. Prothrombin activation by factor X(a) in the absence of factor V(a) and in the absence and presence of membranes.

Authors:  Jogin R Wu; Chaoming Zhou; Rinku Majumder; Daniel D Powers; Gabriel Weinreb; Barry R Lentz
Journal:  Biochemistry       Date:  2002-01-22       Impact factor: 3.162

8.  Cofactor dependence of factor Xa incorporation into the prothrombinase complex.

Authors:  M E Nesheim; C Kettner; E Shaw; K G Mann
Journal:  J Biol Chem       Date:  1981-07-10       Impact factor: 5.157

9.  The role of phospholipids and factor Va in the prothrombinase complex.

Authors:  J Rosing; G Tans; J W Govers-Riemslag; R F Zwaal; H C Hemker
Journal:  J Biol Chem       Date:  1980-01-10       Impact factor: 5.157

10.  The conversion of prothrombin to thrombin. V. The activation of prothrombin by factor Xa in the presence of phospholipid.

Authors:  C T Esmon; W G Owen; C M Jackson
Journal:  J Biol Chem       Date:  1974-12-25       Impact factor: 5.157

View more
  7 in total

1.  Acylcarnitines are anticoagulants that inhibit factor Xa and are reduced in venous thrombosis, based on metabolomics data.

Authors:  Hiroshi Deguchi; Yajnavalka Banerjee; Sunia Trauger; Gary Siuzdak; Ewa Kalisiak; José A Fernández; Linh Hoang; Minerva Tran; Subramanian Yegneswaran; Darlene J Elias; John H Griffin
Journal:  Blood       Date:  2015-07-14       Impact factor: 22.113

2.  Ca2+ switches the effect of PS-containing membranes on Factor Xa from activating to inhibiting: implications for initiation of blood coagulation.

Authors:  Tilen Koklic; Rinku Majumder; Barry R Lentz
Journal:  Biochem J       Date:  2014-09-15       Impact factor: 3.857

Review 3.  Historical perspective and future directions in platelet research.

Authors:  B S Coller
Journal:  J Thromb Haemost       Date:  2011-07       Impact factor: 5.824

Review 4.  Milk fat-globule epidermal growth factor 8: A potential Regulator of Cutaneous Wound Healing.

Authors:  Yun Xiao; Ying Tang; Xiao Shu; Jinshuo Zhu; Xinan Wu; Yuan Zhang
Journal:  Mol Biol Rep       Date:  2022-05-17       Impact factor: 2.742

5.  Phosphatidylserine and FVa regulate FXa structure.

Authors:  Kinshuk Raj Srivasatava; Rinku Majumder; William H Kane; Mary Ann Quinn-Allen; Barry R Lentz
Journal:  Biochem J       Date:  2014-04-01       Impact factor: 3.857

6.  Phosphatidylserine-induced factor Xa dimerization and binding to factor Va are competing processes in solution.

Authors:  Rinku Majumder; Tilen Koklic; Alireza R Rezaie; Barry R Lentz
Journal:  Biochemistry       Date:  2012-12-27       Impact factor: 3.162

7.  Oligomerization, conformational stability and thermal unfolding of Harpin, HrpZPss and its hypersensitive response-inducing c-terminal fragment, C-214-HrpZPss.

Authors:  Pradip K Tarafdar; Lakshmi Vasudev Vedantam; Rajeshwer S Sankhala; Pallinti Purushotham; Appa Rao Podile; Musti J Swamy
Journal:  PLoS One       Date:  2014-12-12       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.